BRCA1 Breast Cancer: Muriel's Survivor Story

What happened, in summary

Muriel Verger was diagnosed with triple-negative breast cancer in 2015, when she was 33 and close to turning 34. She also reported a BRCA1 abnormality. Because the tumor was not large, her surgical treatment was a tumorectomy, also understood as breast-conserving surgery, rather than a mastectomy. Treatment then continued with 6 rounds of chemotherapy and 33 sessions of radiation therapy. She also had a complete axillary dissection because of concern around sentinel lymph nodes that had not been found. The full treatment process lasted about 9 months. Muriel described the physical and emotional burden clearly: chemotherapy caused hair loss, loss of eyelashes and body hair, and major changes in how she saw her body. Surgery also left scars, even without breast removal. She said her treatment was meant to clean out remaining risk and prevent an early recurrence, which mattered because triple-negative breast cancer can recur quickly and become metastatic if not caught early. Muriel used her story to argue for earlier breast awareness, professional exams, and being taken seriously even when young. As of October 2021, the captured story supported completed treatment and survivorship, but it did not report a formal stage or a current no-evidence-of-disease scan result overall.